Cargando…
Movement Disorders in Oncology: From Clinical Features to Biomarkers
Background: the study of movement disorders associated with oncological diseases and anticancer treatments highlights the wide range of differential diagnoses that need to be considered. In this context, the role of immune-mediated conditions is increasingly recognized and relevant, as they represen...
Autores principales: | Marsili, Luca, Vogrig, Alberto, Colosimo, Carlo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8772745/ https://www.ncbi.nlm.nih.gov/pubmed/35052708 http://dx.doi.org/10.3390/biomedicines10010026 |
Ejemplares similares
-
Stem Cell Therapies in Movement Disorders: Lessons from Clinical Trials
por: Marsili, Luca, et al.
Publicado: (2023) -
Diagnostic Criteria for Parkinson’s Disease: From James Parkinson to the Concept of Prodromal Disease
por: Marsili, Luca, et al.
Publicado: (2018) -
Paraneoplastic Neurological Syndromes of the Central Nervous System: Pathophysiology, Diagnosis, and Treatment
por: Marsili, Luca, et al.
Publicado: (2023) -
Deep Brain Stimulation for Movement Disorders – A History of Success and Challenges to Conquer
por: Wojtecki, Lars, et al.
Publicado: (2012) -
Diagnosis and Clinical Features in Autoimmune-Mediated Movement Disorders
por: Hsieh, Pei-Chen, et al.
Publicado: (2022)